Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Savara Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Savara Inc. June 4, 202698.3%
-
Savara Inc. June 5, 202598.7%
-
Savara Inc. June 6, 202499.7%
-
Savara Inc. June 8, 202399.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Halozyme Therapeutics Inc. | Option exercise | +10,000 | — | — |
| Jun 30, 2026 | Halozyme Therapeutics Inc. | Shares withheld for tax | −5,408 | $78.27 | $423,284 |
| Dec 19, 2025 | Savara Inc. | Open-market sale | −20,000 | $6.06 | $121,200 |
| Dec 9, 2025 | Savara Inc. | Grant or award | +40,000 | — | — |
| Mar 31, 2025 | Savara Inc. | Open-market purchase | +150,000 | $2.78 | $417,000 |
| Dec 12, 2024 | Savara Inc. | Grant or award | +40,000 | — | — |
| Nov 18, 2024 | Savara Inc. | Open-market purchase | +100,000 | $2.88 | $288,000 |
| Dec 14, 2023 | Savara Inc. | Grant or award | +22,500 | — | — |
| May 26, 2023 | Savara Inc. | Open-market purchase | +37,124 | $2.63 | $97,636 |
| May 25, 2023 | Savara Inc. | Open-market purchase | +12,876 | $2.57 | $33,091 |
| May 24, 2023 | Savara Inc. | Open-market purchase | +50,000 | $2.56 | $128,000 |
| Dec 30, 2022 | Savara Inc. | Open-market purchase | +29,000 | $1.55 | $44,950 |
| Dec 29, 2022 | Savara Inc. | Open-market purchase | +7,000 | $1.54 | $10,780 |
Questions about David A. Ramsay
What boards is David A. Ramsay on?
David A. Ramsay sits on the board of Savara Inc.
How long has David A. Ramsay served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.